Submitted by newyorkpost9062 in news
Dr. Crystal Glover, a health equity in aging researcher at the Rush Alzheimer’s Disease Center in Chicago, wondered if the new treatments are relevant to the groups who are most at risk.
Submitted by newyorkpost9062 in news
Dr. Crystal Glover, a health equity in aging researcher at the Rush Alzheimer’s Disease Center in Chicago, wondered if the new treatments are relevant to the groups who are most at risk.